Phylogenetic discovery bias in Bacillus anthracis using single-nucleotide polymorphisms from whole-genome sequencing

Proceedings of the National Academy of Sciences of the United States of America
Talima PearsonPaul Keim

Abstract

Phylogenetic reconstruction using molecular data is often subject to homoplasy, leading to inaccurate conclusions about phylogenetic relationships among operational taxonomic units. Compared with other molecular markers, single-nucleotide polymorphisms (SNPs) exhibit extremely low mutation rates, making them rare in recently emerged pathogens, but they are less prone to homoplasy and thus extremely valuable for phylogenetic analyses. Despite their phylogenetic potential, ascertainment bias occurs when SNP characters are discovered through biased taxonomic sampling; by using whole-genome comparisons of five diverse strains of Bacillus anthracis to facilitate SNP discovery, we show that only polymorphisms lying along the evolutionary pathway between reference strains will be observed. We illustrate this in theoretical and simulated data sets in which complex phylogenetic topologies are reduced to linear evolutionary models. Using a set of 990 SNP markers, we also show how divergent branches in our topologies collapse to single points but provide accurate information on internodal distances and points of origin for ancestral clades. These data allowed us to determine the ancestral root of B. anthracis, showing that it lies closer ...Continue Reading

References

Jul 1, 1995·Journal of Clinical Microbiology·L J HarrellK H Wilson
Oct 4, 2000·Journal of Clinical Microbiology·K L SmithP Keim
Nov 28, 2002·Journal of Clinical Microbiology·Agnès FouetPaul Keim
Sep 29, 2004·Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases·Paul KeimDavid M Wagner

❮ Previous
Next ❯

Citations

Apr 12, 2005·International Journal of Legal Medicine·Bruce BudowleRanajit Chakraborty
Feb 1, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M AntwerpenD Frangoulidis
Apr 6, 2005·FEMS Microbiology Reviews·David A RaskoJacques Ravel
Apr 24, 2007·The Lancet Infectious Diseases·Sebastien Gagneux, Peter M Small
Oct 13, 2009·Nature Reviews. Microbiology·Paul S Keim, David M Wagner
Mar 12, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shannon D ManningThomas S Whittam
Sep 6, 2008·Proceedings of the National Academy of Sciences of the United States of America·Ulrich NübelMark Achtman
Mar 9, 2011·Proceedings of the National Academy of Sciences of the United States of America·David A RaskoJacques Ravel
Nov 6, 2013·Biosecurity and Bioterrorism : Biodefense Strategy, Practice, and Science·Sylviane Derzelle, Simon Thierry
Oct 26, 2006·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Konstantinos T KonstantinidisJames M Tiedje
Nov 25, 2006·Science·Philippe RoumagnacMark Achtman
May 20, 2008·Applied and Environmental Microbiology·Pierre WattiauHein Imberechts
Jul 10, 2012·Applied and Environmental Microbiology·Chad W Stratilo, Douglas E Bader
Nov 24, 2006·Applied and Environmental Microbiology·Nicholas H BergmanZhaohui S Qin
Feb 10, 2009·Journal of Bacteriology·Jeffrey T FosterPaul Keim
Mar 3, 2009·Journal of Bacteriology·Amy J VoglerPaul Keim
May 20, 2005·Journal of Bacteriology·Kerstin SvenssonAnders Johansson
Aug 31, 2007·Journal of Clinical Microbiology·Sophie Octavia, Ruiting Lan
Nov 10, 2006·Journal of Clinical Microbiology·Matthew N Van ErtPaul Keim
Nov 23, 2007·Journal of Clinical Microbiology·Jeffrey T FosterPaul Keim
Mar 30, 2007·Journal of Clinical Microbiology·David SuePatricia P Wilkins
Jul 8, 2005·Journal of Clinical Microbiology·Antonio FasanellaPaul Keim
Mar 7, 2006·Journal of Clinical Microbiology·Chad W StratiloDoug Bader
Jun 12, 2009·Annual Review of Microbiology·Anne-Brit KolstøOle Andreas Økstad
Jun 21, 2012·BMC Genomics·Kenneth D DoigTimothy P Stinear
Nov 28, 2012·BMC Genomics·Sebastián Aguilar PierléKelly A Brayton

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Related Papers

Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases
Paul KeimDavid M Wagner
Journal of Clinical Microbiology
Antonio FasanellaPaul Keim
© 2021 Meta ULC. All rights reserved